On January 11, 2021, Entheon Biomedical Corp. (CNSX:ENBI) closed the transaction. The company has issued 53,521 units for gross proceeds of CAD 40,140.75 in its second tranche bringing the total funds raised in the transaction to CAD 3,214,515. The company received CAD 40,141.532 from 1 investor pursuant to exemption provided under Regulation D.